Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey

Caitrin Crudden1,2, Dawei Song3, Sonia Cismas4

  • 1Department of Oncology-Pathology, Cellular and Molecular Tumor Pathology, Karolinska Institute, and Karolinska University Hospital, 17164 Stockholm, Sweden. c.crudden@amsterdamumc.nl.

Cells
|October 12, 2019
PubMed

Insights

Receptor endocytosis is not just for signal termination but actively regulates cell signaling. The endosome acts as a platform, controlling receptor localization and function, impacting biological outcomes.

Area of Science:

  • Cell biology
  • Molecular signaling
  • Cancer research

Background:

  • Ligand-activated plasma membrane receptors internalize via endocytosis.
  • The endosomal sorting apparatus processes receptors and ligands for recycling or degradation.
  • Traditionally, endocytosis was viewed primarily for signal termination.

Purpose of the Study:

  • To explore the emerging paradigm of endocytosis as a regulator of receptor signaling.
  • To discuss the role of the endosomal platform in governing receptor function.
  • To examine this perspective in the context of the insulin-like growth factor type 1 receptor (IGF-1R) in cancer.

Main Methods:

  • Review of current literature on receptor endocytosis and signaling.
  • Analysis of the endosomal platform's role in spatial and temporal receptor signaling.
  • Focus on the insulin-like growth factor type 1 receptor (IGF-1R) as a model.

Main Results:

  • Endocytosis is now understood to govern the spatial and temporal aspects of receptor signaling.
  • The endosome acts as a master regulator, controlling receptor localization, post-translational modifications, and scaffolding.
  • This endosomal platform dictates how cells interpret and translate receptor signals into biological effects.

Conclusions:

  • The endosomal platform is a critical regulatory hub for receptor signaling, extending beyond signal termination.
  • Understanding this paradigm is crucial for interpreting cellular responses to receptor activation.
  • This perspective offers new insights for developing targeted cancer therapies, particularly for IGF-1R.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
GPI Anchoring of Proteins in the ER Membrane01:29

GPI Anchoring of Proteins in the ER Membrane

GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
5.2K
ER Retrieval Pathway01:45

ER Retrieval Pathway

In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
4.6K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K